Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
Clinical trial NCT04463264 · UNKNOWN
Trial details
- NCT number
- NCT04463264
- Sponsor
- Laboratorios Roemmers S.A.I.C.F.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-26
- Primary completion
- 2020-11-15
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.